Literature DB >> 9237679

Human free secretory component is composed of the first 585 amino acid residues of the polymeric immunoglobulin receptor.

G J Hughes1, S Frutiger, L A Savoy, A J Reason, H R Morris, J C Jaton.   

Abstract

The main objective of this work was to unequivocally determine the C-terminal sequence of human milk free secretory component (SC). It was found to end at arginine-585, i.e. 33 amino acids downstream from the major heterogeneous C-terminal residue previously identified for colostrum SC. In contrast, our data showed that the C-terminal end of SC was found to be homogeneous. Conflicting assignments, Asp/Gln, a missing Asn-211, Asp/Asn, Glu/Gln were corrected and found to agree with the cDNA sequence. An Ala/Val substitution at position 562 (domain VI) was identified. Its genetic significance is uncertain at present.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9237679     DOI: 10.1016/s0014-5793(97)00629-7

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  4 in total

Review 1.  Epithelial transcytosis of immunoglobulins.

Authors:  W Hunziker; J P Kraehenbuhl
Journal:  J Mammary Gland Biol Neoplasia       Date:  1998-07       Impact factor: 2.673

2.  Multiple cleavage sites for polymeric immunoglobulin receptor.

Authors:  Masatake Asano; Nobuko Takenouchi-Ohkubo; Naoyuki Matsumoto; Yoshitaka Ogura; Hirofumi Nomura; Hisashi Suguro; Itaru Moro
Journal:  Immunology       Date:  2004-08       Impact factor: 7.397

3.  Reduced immunoglobulin A transcytosis associated with immunoglobulin A nephropathy and nasopharyngeal carcinoma.

Authors:  Tao Su; Steven J Chapin; David M Bryant; Annette M Shewan; Kitty Young; Keith E Mostov
Journal:  J Biol Chem       Date:  2011-11-15       Impact factor: 5.157

4.  Polymeric immunoglobulin receptor polymorphisms and risk of nasopharyngeal cancer.

Authors:  Rungnapa Hirunsatit; Narisorn Kongruttanachok; Kanjana Shotelersuk; Pakpoom Supiyaphun; Narin Voravud; Anavaj Sakuntabhai; Apiwat Mutirangura
Journal:  BMC Genet       Date:  2003-01-21       Impact factor: 2.797

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.